Sechenov School
Home › Pharmacology › Drug Action Targets

Drug Action Targets

For medical students2 min readUpdated 2026-10-10

Drug action targets are structures or processes within the body with which a medication interacts to produce a therapeutic effect. In addition to classic cellular receptors, drugs can directly target ion channels, various enzymes, transport proteins, and in some cases, work through direct chemical reactions or physicochemical properties.

Basic PrincipleA drug binds to its target molecule, altering the physiological functions of cells.
Target-Free ActionSome medications work solely through their basic physicochemical properties.
GeneticsGenes are considered a promising target for selective cellular modulation.

Ion Channels as Pharmacotherapy Targets

Many drugs alter the permeability of cell membranes to ions by acting as blockers or activators of specific channels.

Enzymes and Transport Systems

Pharmacological action on enzymes generally consists of their inhibition (suppression of activity), which alters the concentration of important endogenous substances in the body.

  1. Monoamine oxidase (MAO) inhibitors. These block the enzyme that degrades catecholamines. This leads to the accumulation of serotonin, dopamine, and norepinephrine in the CNS (used as antidepressants, e.g., nialamide).
  2. Nonsteroidal anti-inflammatory drugs (NSAIDs). Their target is the cyclooxygenase enzyme. Suppressing its activity decreases prostaglandin synthesis, providing a potent anti-inflammatory effect.
  3. Anticholinesterase agents. These block the enzyme acetylcholinesterase, halting the breakdown of acetylcholine. The accumulation of this neurotransmitter in the synaptic cleft increases the tone of skeletal muscle and smooth muscle organs (gastrointestinal tract, urinary bladder).

Transport systems also serve as important targets. Drugs bind to carrier proteins or ion pumps:

Structural Proteins and Extracellular Mechanisms

Some medications act on the cellular cytoskeleton. For example, the target for antineoplastic agents (vinca alkaloids) is the structural protein tubulin. These drugs bind to its monomers, preventing microtubule assembly. This produces an antimitotic effect—malignant cells lose their ability to divide.

There is also chemical interaction, where the effect is achieved through direct extracellular reactions rather than via receptors. A classic example is antacids. They simply neutralize excess hydrochloric acid in the stomach chemically, which helps with hyperacid gastritis and peptic ulcer disease.

Finally, a number of agents lack specific biological targets altogether, working exclusively based on their physicochemical properties. The osmotic diuretic mannitol increases osmotic pressure in the renal tubules. Water stops being reabsorbed, is retained within the tubular lumen, and diuresis increases significantly.

Mnemonic

The effects of calcium channel blockers are easily remembered by the "Three S's": Vessels (Smooth muscle relaxation), Heart (Slower rate), Speed of conduction (decreased in the AV node).

Frequently asked questions

Which enzymes are targets for drug action?

Targets for drug action include human bodily enzymes as well as enzymes of pathogens. Sources list the following target enzymes:

  • Monoamine oxidase (MAO) — responsible for the oxidative deamination of catecholamines; MAO inhibitors disrupt metabolism and cause the accumulation of norepinephrine, dopamine, and serotonin in the CNS.
  • Cyclooxygenase (COX) — target of NSAIDs; inhibition reduces prostaglandin biosynthesis.
  • Acetylcholinesterase — target of anticholinesterase agents; blockade of acetylcholine hydrolysis increases its concentration in the synaptic cleft.
  • Phosphodiesterase-III (PDE-III) — target of milrinone; selective inhibition in cardiomyocytes leads to intracellular cAMP accumulation.
  • Angiotensin-converting enzyme (ACE) — participates in angiotensin II formation within the vascular bed; ACE inhibition also prevents bradykinin degradation.
  • Catechol-O-methyltransferase (COMT) — an enzyme whose inhibitors are used to increase levodopa efficacy.
  • Dihydrofolate reductase — target of methotrexate; overexpression of this enzyme is a resistance mechanism.
  • $H^+/K^+$-ATPase — the proton pump of gastric parietal cells.
  • $Na^+$-$K^+$-ATPase — the sodium-potassium pump of cardiomyocytes, blocked by cardiac glycosides.
  • Reverse transcriptase, integrase, and protease — viral enzymes whose inhibition is the target of antiviral therapy.
Which drugs act via direct extracellular chemical reactions?

Sources describe the following agents and substances acting via direct chemical reactions or extracellular chemical interactions:

  • Antacids — neutralize hydrochloric acid in the stomach chemically.
  • Antidotes in chemical antagonism — undergo chemical reactions to form inactive compounds:
  • Sodium thiosulfate forms non-toxic sulfites in heavy metal poisoning;
  • Digibind binds cardiac glycosides into inactive complexes;
  • Protamine sulfate binds to heparin and neutralizes its anticoagulant effect.
  • Protamine sulfate — forms an insoluble complex with heparin during severe hemorrhage associated with heparin, causing chemical neutralization.
  • Potassium permanganate — causes chemical oxidation of morphine during gastric lavage for acute morphine poisoning.
  • Components of the "Carisolv" kit for chemomechanical caries removal: gel No. 1 dissolves degraded mineral components of carious dentin, and gel No. 2 with sodium hypochlorite dissolves exposed collagen fibers.
Which transport systems serve as targets for drugs?

Targets for drugs include carrier proteins and ion pumps, the disruption of which alters transmembrane transport. Sources list the following transport systems:

  • Presynaptic membrane transport proteins — blocked by tricyclic antidepressants; this disrupts neuronal reuptake of norepinephrine and serotonin and increases their concentration in the synapse.
  • Cardiomyocyte $Na^+$-$K^+$-ATPase — blocked by cardiac glycosides; disrupts $Na^+$ transport out of the cell in exchange for $K^+$.
  • NKCC2 — sodium-potassium-chloride cotransporter of the apical membrane of epithelial cells in the thick ascending limb of the loop of Henle; selective blockade inhibits this carrier protein's function.
  • NCC — sodium-chloride cotransporter of the distal convoluted tubule; its blockade impairs sodium and chloride ion reabsorption.
  • P-glycoprotein — a transporter protein whose activity can be altered by drugs or dietary components, changing the plasma concentrations of its substrates.
Which receptors are coupled to G proteins?

G protein-coupled receptors (metabotropic receptors) are the most common type of receptors in the human body. Key representatives of this group include:

  • Dopamine receptors.
  • Serotonin receptors (certain subtypes).
  • Opioid receptors.
  • Histamine receptors.
  • Receptors for most peptide hormones.
  • $\beta_1$-adrenergic receptors — coupled to the $G_s$ protein, which activates adenylate cyclase.
What types of ion channels exist based on their opening mechanism?

Sources do not provide a complete classification of ion channels by opening mechanism, but mention the following types:

  • Voltage-gated channels — e.g., voltage-gated $Ca^{2+}$ channels, which open upon membrane depolarization; also describes voltage-gated $Ca^{2+}$ channel opening in $\beta$-cells.
  • ATP-sensitive channels — e.g., ATP-sensitive $K^+$ channels of $\beta$-cells, whose closure is linked to rising ATP concentration.
  • Receptors directly coupled to ion channels, or ionotropic receptors — one type of membrane receptor.
  • $GABA_A$ receptor complex — linked to chloride channels; sodium thiopental leads to prolonged activation of chloride channels and chloride influx into the cell.
  • Test sources also mention ligand-gated calcium channels.
How do drugs without specific targets work?

Their action is driven exclusively by physicochemical properties. For example, the diuretic mannitol simply increases osmotic pressure in the kidneys, retaining water and increasing urine output without receptor binding.

What is the mechanism of action of nonsteroidal anti-inflammatory drugs?

NSAIDs inhibit the enzyme cyclooxygenase (COX). This leads to decreased biosynthesis of prostaglandins, ultimately providing an anti-inflammatory effect.

How do potassium channel activators work?

They open channels, promoting the efflux of potassium ions out of the cell. This causes cell membrane hyperpolarization, reduced vascular smooth muscle tone, and a drop in blood pressure.

Go deeper

More topics in Pharmacology

EtomidateCentral Anticholinesterase DrugsNon-Selective Alpha-BlockersEthosuximideDaclizumabEffect of Food and GI Motility on Drug AbsorptionTrimeperidine (Promedol)Barbiturates (Hypnotics)Pathophysiology of PainProtease InhibitorsAlpha, Beta-BlockersPharmacotherapy of Acute Heart FailurePharmacology →